Biotech

All Articles

Takeda takes $140M loss on fallen short epilepsy medicine, touts FDA manage

.We presently understand that Takeda is planning to locate a path to the FDA for epilepsy medication...

VBI Injections declare personal bankruptcy, looks for property sale

.Immunology biotech VBI Vaccines is actually veering precariously close to the defining moment, alon...

Celldex anti-cKIT antibody reduce hives in yet another stage 2 research study

.It's hard to muscular tissue in on an area as reasonable as immunology, yet Celldex Therapies feels...

Boehringer offers up to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapeutics as well as a pr...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's illness medication performed certainly not help people obtain remission...

Cognition's stage 2 SHINE data blemish Alzheimer's possibility

.Cognition Therapeutics' stage 2 luster trial has actually taken some of the appeal off the Alzheime...

BMS centers bispecific months after filing to function stage 3 trial

.Bristol Myers Squibb has actually had a whiplash change of heart on its BCMA bispecific T-cell enga...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion purchase to Bristol Myers...

Asarina to close after initiatives to partner Tourette's drug fail

.After reaching out to much more than 200 firms to partner a Tourette disorder treatment that showed...

Novartis pens $150M upfront bispecifics manage Dren Biography

.Novartis has actually possessed some rotten luck with bispecific antitoxins over the last, yet judg...